XOLAIR
NDC 50242-040 · Genentech, Inc.
Generic nameomalizumab
Dosage formINJECTION, SOLUTION
RouteSUBCUTANEOUS
Active ingredient(s)OMALIZUMAB
Strength150 mg/1.2mL
Pharmacologic classAnti-IgE [EPC], Decreased IgE Activity [PE], IgE-directed Antibody Interactions [MoA]
Marketing categoryBLA
Packages
50242-040-62 — 1 VIAL, SINGLE-USE in 1 CARTON (50242-040-62) / 1.2 mL in 1 VIAL, SINGLE-USE
50242-040-86 — 1 VIAL, SINGLE-USE in 1 CARTON (50242-040-86) / 1.2 mL in 1 VIAL, SINGLE-USE
Billed under HCPCS
J2357 — Injection, omalizumab, 5 mg Medicare Part B payment limit (ASP + 6%): $46.59
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
50242-214 — omalizumab, 50242-215 — omalizumab, 50242-227 — omalizumab